Hyperleptinemia - Non-Haemodynamic Risk Factor for the Left Ventricular Hypertrophy Development in Hypertensive Overweight Females

被引:0
|
作者
Selthofer-Relatic, Kristina [1 ]
Radic, Radivoje [3 ]
Vizjak, Vedrana [1 ]
Vcev, Aleksandar [1 ]
Kosovic, Pasezada [2 ]
Bosnjak, Ivica [1 ]
Selthofer, Robert [3 ]
机构
[1] Univ Hosp Osijek, Clin Internal Med, Osijek, Croatia
[2] Univ Hosp Osijek, Dept Nucl Med, Osijek, Croatia
[3] Univ JJ Strossmayer, Fac Med, Dept Anat, Osijek, Croatia
关键词
leptin; obesity; hypertension; left ventricular hypertrophy;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Obesity is directly and strongly associated with hypertension and left ventricular hypertrophy (LVH). Development of LVH is multifactorial, caused both by haemodynamic and non-haemodynamic factors. Hypertension is the main haemodynamic factor. Humoral mechanisms, as a non-haemodynamic factor for LVH development, have not been completely explained. The aim of this study is to determine whether hyperleptinemia can be one of humoral - non-haemodynamic factor inducing LVH together with haemodynamic factors in overweight females. The study was done on thirty six adult, overweight female patients, body mass index in range 25-30 kg/m(2). Patients are nondiabetic with regular renal function. Twenty one female patients were hypertensive with left ventricular hypertrophy. Control group included fifteen hypertensive female patients without left ventricular hypertrophy. In all patients was determined glucose profile and creatinine clearance, cholesterol, triglycerides, LDL, HDL. Weight, high, circumference of the waist and hips was taken. Cardiovascular determination was done applying two-dimensional ultrasound. Serum leptin level was measured using radioimmunoassay method (RIA). Results showed that serum leptin level was significantly higher in hypertensive, overweight females with LVH. This suggests that non-haemodynamic factors, such as hyperleptinemia, participate in left ventricular hypertrophy development together with haemodynamic factors in adult hypertonic, overweight females.
引用
收藏
页码:681 / 685
页数:5
相关论文
共 50 条
  • [1] EFFECT OF LEPTIN ON THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS
    Kardesoglu, Ejder
    Demiralp, Egun
    Cebeci, Bekir Sitki
    Ozmen, Namik
    Celik, Turgay
    Top, Cihan
    Cingozbay, Bekir Yilmaz
    Yalcin, Murat
    NOBEL MEDICUS, 2006, 2 (01): : 10 - +
  • [2] Development of a nomogram for screening the risk of left ventricular hypertrophy in Chinese hypertensive patients
    Ye, Chaoyi
    Wang, Tingjun
    Gong, Jin
    Cai, Xiaoqi
    Lian, Guili
    Luo, Li
    Wang, Huajun
    Xie, Liangdi
    JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (06) : 1176 - 1185
  • [3] Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy
    Frohlich, Edward D.
    Gonzalez, Arantxa
    Diez, Javier
    JOURNAL OF HYPERTENSION, 2011, 29 (01) : 17 - 26
  • [4] Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network
    Izzo, Raffaele
    Losi, Maria-Angela
    Stabile, Eugenio
    Loennebakken, Mai Tone
    Canciello, Grazia
    Esposito, Giovanni
    Barbato, Emanuele
    De Luca, Nicola
    Trimarco, Bruno
    de Simone, Giovanni
    HYPERTENSION, 2017, 69 (01) : 136 - 142
  • [5] Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects
    R L Antikainen
    T Grodzicki
    D G Beevers
    J Webster
    J J Jokelainen
    C J Bulpitt
    Journal of Human Hypertension, 2009, 23 : 20 - 26
  • [6] Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects
    Antikainen, R. L.
    Grodzicki, T.
    Beevers, D. G.
    Webster, J.
    Jokelainen, J. J.
    Bulpitt, C. J.
    JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (01) : 20 - 26
  • [7] Risk Factors of Development of Left Ventricular Hypertrophy in Patients With Hypertensive Disease With High Compliance to Treatment
    Koziolova, N. A.
    Shatunova, I. M.
    Lazarev, I. A.
    KARDIOLOGIYA, 2012, 52 (04) : 25 - 30
  • [8] The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy
    Thu-Thao Le
    Lim, Vanessa
    Ibrahim, Rositaa
    Muh-Tyng Teo
    Bryant, Jennifer
    Ang, Briana
    Su, Boyang
    Aw, Tar-Choon
    Lee, Chi-Hang
    Bax, Jeroen
    Cook, Stuart
    Chin, Calvin W. L.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (06) : 670 - 679
  • [9] Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population
    Tanaka, Kentaro
    Tanaka, Fumitaka
    Onoda, Toshiyuki
    Tanno, Kozo
    Ohsawa, Masaki
    Sakata, Kiyomi
    Omama, Shinichi
    Ogasawara, Kuniaki
    Ishibashi, Yasuhiro
    Itai, Kazuyoshi
    Kuribayashi, Toru
    Okayama, Akira
    Nakamura, Motoyuki
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (08) : 895 - 901
  • [10] Establishment of an Individual-Specific Nomogram for Predicting the Risk of Left Ventricular Hypertrophy in Chinese Postmenopausal Hypertensive Women
    Yuan, Ruowen
    Chen, Jianshu
    Zhang, Shangyun
    Zhang, Xiaowei
    Yu, Jing
    MEDICINA-LITHUANIA, 2023, 59 (03):